Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kurniamitra Duta Sentosa Tbk. (KMDS) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Kurniamitra Duta Sentosa Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Kurniamitra Duta Sentosa Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Kurniamitra Duta Sentosa Tbk. trades at Rp535 (market cap 432B, 231.2K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 231.2K). Which is the better fit depends on your goals.

KMDSLABS
Market Cap
432B576.7B
Volume
231.2K3.48M
Lot
2.31K34.82K
Turnover
124.58M522.79M
Average Price
538.82150.13
Value
124.58M522.79M
Indicative Equilibrium Price
530148
Indicative Equilibrium Volume
5350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KMDS
View details
LABS
View details

About Kurniamitra Duta Sentosa Tbk.

PT Kurniamitra Duta Sentosa Tbk ("Company") was established based on Deed No. 21 July 17, 2000, which was made before the Notary Kun Hidayat, SH. The company started its commercial operations since July 17, 2000

Read more on KMDS

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS